Xcout Intel
PridCor Therapeutics, LLC competitors & alternatives
The 12 closest competitors and alternatives to PridCor Therapeutics, LLC — ranked by similarity to what PridCor Therapeutics, LLC actually does, not by market-cap band.
Subscribe to see PridCor Therapeutics, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About PridCor Therapeutics, LLC
PridCor Therapeutics, LLC is a privately held, clinical-stage biopharmaceutical company headquartered in Tuscaloosa, Alabama, focused on developing novel antiviral therapies and securing global antiviral portfolios.
PridCor Therapeutics, LLC at a glance
PridCor Therapeutics, LLC is a company headquartered in United States. Its most recent funding round raised $6M in May 2026. Xcout tracks 6 named people at PridCor Therapeutics, LLC, including William L. Pridgen (Chief Executive Officer).
PridCor Therapeutics, LLC leadership
- William L. PridgenChief Executive Officer
- Dr. William PridgenFounder and Chief Executive Officer
- William PridgenFounder and Chief Executive Officer
- Brian CordayExecutive Officer
- Brian L CordayExecutive Officer
- William L. PridgenExecutive Officer
PridCor Therapeutics, LLC funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $6M | — | |
| SEC Form D filing | $1M | — | |
| — | $40,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent PridCor Therapeutics, LLC news
- FundingPrivate placement (Form D)
Top 12 PridCor Therapeutics, LLC competitors
Ranked by semantic similarity — how close each company is to PridCor Therapeutics, LLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Carlsbad, California. The company focuses on the development of novel oral antiviral treatments for viral diseases.
Close match by what they do
Khaya Biosciences, Inc., also known as Khaya Bio, Inc., is a bioscience company with its principal office address located in Dothan, Alabama.
Biotechnology
Red Queen Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on antiviral therapeutics, with its headquarters located in Cambridge, Massachusetts.
Close match by what they do
PrEP Biopharm Ltd is a biopharmaceutical company located in northern Italy that develops antiviral drugs and therapeutic pipelines.
Close match by what they do
Iaso Therapeutics, Inc. is a biopharmaceutical and biotechnology company headquartered in East Lansing, Michigan, dedicated to redefining infectious disease prevention and drug research.
Pharmaceuticals, Biotechnology & Life Sciences
Island Pharmaceuticals Ltd is an Australian antiviral drug development company based in Melbourne, Australia, focused on addressing infectious diseases.
Biotechnology
Agenovir is a biotechnology company focused on developing antiviral therapeutics, particularly for herpesvirus infections. Its intended beneficiaries are patients with viral diseases and the healthcare providers who treat them.
Close match by what they do
ContraVir Pharmaceuticals, Inc. is a biopharmaceutical company with principal executive offices located in Edison, New Jersey. The corporation focuses on researching and developing pharmaceutical therapies.
Close match by what they do
Arrevus, Inc. is a clinical-stage biopharmaceutical company located in Raleigh, North Carolina. The company specializes in developing innovative therapies to treat orphan and rare infectious diseases.
Pharmaceuticals
Cocrystal Pharma, Inc. (COCP) is a biotechnology firm dedicated to researching and advancing antiviral treatments for severe and/or persistent viral illnesses. The company leverages structure-based technologies to create new antiviral medications, primarily focusing on infections caused by the hepatitis C virus (HCV), influenza, coronaviruses, and noroviruses. Its current pipeline includes CC-31244, a non-nucleoside polymerase inhibitor for HCV, which has successfully completed Phase IIa clinical trials. Additionally, CC-42344, a PB2 inhibitor designed to combat influenza, is currently undergoing preclinical development. Cocrystal Pharma is also actively pursuing the development of non-nucleoside polymerase inhibitors to address norovirus infections. The company maintains strategic alliances, including a research and licensing collaboration with Merck Sharp & Dohme Corp. for the discovery and development of proprietary influenza A/B antiviral agents. It also holds a licensing agreement with the Kansas State University Research Foundation, aimed at advancing antiviral compounds for norovirus and coronavirus infections. Furthermore, Cocrystal Pharma engages in drug discovery collaborations with both HitGen and InterX Inc. The company's operations are headquartered in Bothell, Washington.
Close match by what they do
GeneCapture, Inc. is a biotechnology company headquartered in Huntsville, Alabama, that has developed a portable rapid diagnostic platform for identifying pathogens and antimicrobial resistance.
Close match by what they do
Thylacine Biotherapeutics Inc. is a privately held biotech company headquartered in Miami Beach, Florida, dedicated to combating infectious diseases. The company develops a drug pipeline addressing both commercial and biothreat indications, including novel antiviral peptides.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of PridCor Therapeutics, LLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for PridCor Therapeutics, LLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →